Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2010, Article ID 729876, 8 pages
Research Article

Combination PPAR and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

1Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
2University of Colorado Cancer Center, University of Colorado Denver, Aurora, CO 80045, USA
3Department of Molecular Oncology, Ligand Pharmaceuticals, San Diego, CA 92121, USA

Received 11 May 2009; Accepted 28 July 2009

Academic Editor: Dipak Panigrahy

Copyright © 2010 Joshua P. Klopper et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Complete microarray data set of A375(DRO) after rexinoid, TZD and combination therapy for 24 hours using the Affymetrix GeneChip Human Genome U133A platform.

  1. Supplementary Material